0.014325 0.000000 0.000000 0.000000 0.011818 0.000000 0.000000 0.000000 0.010332 0.00000 0.00000 0.00000 Rotonda, J. Becker, J.W. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 8 90.00 90.00 90.00 69.810 84.620 96.790 C2 H4 O 44.053 ACETYL GROUP non-polymer C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H9 N O3 119.119 (3S)-3-amino-4-hydroxybutanoic acid peptide-like C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking H2 O 18.015 WATER non-polymer C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Nat.Struct.Biol. NSBIEW 2024 1072-8368 3 619 625 10.1038/nsb0796-619 8673606 The three-dimensional structure of apopain/CPP32, a key mediator of apoptosis. 1996 UK Nature NATUAS 0006 0028-0836 376 37 Identification and Inhibition of the Ice/Ced-3 Protease Necessary for Mammalian Apoptosis 1995 10.2210/pdb1pau/pdb pdb_00001pau 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 293 1 AREA DETECTOR 1995-11-09 SIEMENS GRAPHITE(002) M x-ray 1 1.5418 1.0 1.5418 ROTATING ANODE RIGAKU RUH2R 16639.902 APOPAIN 3.4.22.- 1 man polymer 11910.604 APOPAIN 3.4.22.- 1 man polymer 488.489 ACE-ASP-GLU-VAL-ASJ 1 syn polymer 18.015 water 34 nat water CASPASE-3, CPP32, YAMA CASPASE-3, CPP32, YAMA no no SGISLDNSYKMDYPEMGLCIIINNKNFHKSTGMTSRSGTDVDAANLRETFRNLKYEVRNKNDLTREEIVELMRDVSKEDH SKRSSFVCVLLSHGEEGIIFGTNGPVDLKKITNFFRGDRCRSLTGKPKLFIIQACRGTELDCGIETD SGISLDNSYKMDYPEMGLCIIINNKNFHKSTGMTSRSGTDVDAANLRETFRNLKYEVRNKNDLTREEIVELMRDVSKEDH SKRSSFVCVLLSHGEEGIIFGTNGPVDLKKITNFFRGDRCRSLTGKPKLFIIQACRGTELDCGIETD A polypeptide(L) no no SGVDDDMACHKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVNRKVATEFESFSFDAT FHAKKQIPCIVSMLTKELYFYH SGVDDDMACHKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVNRKVATEFESFSFDAT FHAKKQIPCIVSMLTKELYFYH B polypeptide(L) no yes (ACE)DEV(ASJ) XDEVX C polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo Escherichia sample 9606 Homo sapiens 562 Escherichia coli human Homo Escherichia sample 9606 Homo sapiens 562 Escherichia coli 1 2.47 51. VAPOR DIFFUSION, HANGING DROP 5.0 HANGING DROP VAPOR DIFFUSION. 1.5 MICROLITER DROPS OF PROTEIN:INHIBITOR SOLUTION (8.7 MG/ML IN 10 MILLIMOLAR TRIS-HCL PH 8.5, 10 MILLIMOLAR DTT, 3 MILLIMOLAR SODIUM AZIDE) WERE MIXED WITH AN EQUAL VOLUME OF RESERVOIR BUFFER (7% PEG-6000 (W/W), 0.10 MOLAR SODIUM CITRATE PH 5.0, 10 MILLIMOLAR DTT, 3 MILLIMOLAR SODIUM AZIDE) AND INCUBATED AT ROOM TEMPERATURE, vapor diffusion - hanging drop 5.0-8.0 pdbx_database_status struct_conf struct_conf_type database_2 pdbx_initial_refinement_model struct_conn repository Initial release Version format compliance Atomic model Database references Derived calculations Non-polymer description Structure summary Version format compliance Other Derived calculations Other Database references Derived calculations Refinement description 1 0 1997-07-07 1 1 2008-03-24 1 2 2011-07-13 1 3 2012-12-12 1 4 2017-11-29 1 5 2023-08-09 _pdbx_database_status.process_site _database_2.pdbx_DOI _database_2.pdbx_database_accession _struct_conn.pdbx_dist_value _struct_conn.pdbx_leaving_atom_flag _struct_conn.ptnr1_auth_asym_id _struct_conn.ptnr1_auth_comp_id _struct_conn.ptnr1_auth_seq_id _struct_conn.ptnr1_label_asym_id _struct_conn.ptnr1_label_atom_id _struct_conn.ptnr1_label_comp_id _struct_conn.ptnr1_label_seq_id _struct_conn.ptnr2_auth_comp_id _struct_conn.ptnr2_auth_seq_id _struct_conn.ptnr2_label_atom_id _struct_conn.ptnr2_label_comp_id _struct_conn.ptnr2_label_seq_id Y BNL 1996-06-06 REL REL HOH water THE INHIBITOR IS COVALENTLY CONNECTED TO CYS OF THE ENZYME TO FORM A HEMITHIOKETAL. AMINO ACID RESIDUES ARE NUMBERED TO FACILITATE COMPARISON WITH THE INTERLEUKIN 1-BETA CONVERTING ENZYME (ICE, PDB ENTRY 1ICE). RESIDUES IN APOPAIN ARE ASSIGNED THE NUMBERS OF THE HOMOLOGOUS RESIDUES IN THE ALIGNED THREE-DIMENSIONAL STRUCTURE OF ICE. APOPAIN SEQUENCE NUMBERS ARE OMITTED WHEN NO ICE-RELATED RESIDUE IS PRESENT IN APOPAIN, AND APOPAIN-SPECIFIC INSERTIONS ARE INDICATED BY THE ADDITION OF LETTERS TO THE ICE SEQUENCE NUMBERS. 1ICE PROTEIN COMPONENT OF INTERLEUKIN-1BETA CONVERTING ENZYME (PDB ENTRY 1ICE) PDB experimental model Inhibitor Ac-Asp-Glu-Val-Asp-Aldehyde Peptide-like HOH 601 4 HOH HOH 601 A HOH 602 4 HOH HOH 602 A HOH 606 4 HOH HOH 606 A HOH 609 4 HOH HOH 609 A HOH 611 4 HOH HOH 611 A HOH 615 4 HOH HOH 615 A HOH 617 4 HOH HOH 617 A HOH 620 4 HOH HOH 620 A HOH 621 4 HOH HOH 621 A HOH 624 4 HOH HOH 624 A HOH 625 4 HOH HOH 625 A HOH 627 4 HOH HOH 627 A HOH 628 4 HOH HOH 628 A HOH 630 4 HOH HOH 630 A HOH 631 4 HOH HOH 631 A HOH 632 4 HOH HOH 632 A HOH 633 4 HOH HOH 633 A HOH 634 4 HOH HOH 634 A HOH 603 4 HOH HOH 603 B HOH 604 4 HOH HOH 604 B HOH 605 4 HOH HOH 605 B HOH 607 4 HOH HOH 607 B HOH 608 4 HOH HOH 608 B HOH 610 4 HOH HOH 610 B HOH 612 4 HOH HOH 612 B HOH 613 4 HOH HOH 613 B HOH 614 4 HOH HOH 614 B HOH 616 4 HOH HOH 616 B HOH 618 4 HOH HOH 618 B HOH 622 4 HOH HOH 622 B HOH 623 4 HOH HOH 623 B HOH 626 4 HOH HOH 626 B HOH 629 4 HOH HOH 629 B HOH 619 4 HOH HOH 619 C n 1 145 A n 2 146 A n 3 147 A n 4 148 A n 5 149 A ASP 150 n 6 ASP 150 A ASN 151 n 7 ASN 151 A SER 152 n 8 SER 152 A TYR 153 n 9 TYR 153 A LYS 154 n 10 LYS 154 A MET 155 n 11 MET 155 A ASP 156 n 12 ASP 156 A TYR 156 n 13 A TYR 156 A PRO 161 n 14 PRO 161 A GLU 162 n 15 GLU 162 A MET 162 n 16 A MET 162 A GLY 163 n 17 GLY 163 A LEU 164 n 18 LEU 164 A CYS 165 n 19 CYS 165 A ILE 166 n 20 ILE 166 A ILE 167 n 21 ILE 167 A ILE 168 n 22 ILE 168 A ASN 169 n 23 ASN 169 A ASN 170 n 24 ASN 170 A LYS 171 n 25 LYS 171 A ASN 172 n 26 ASN 172 A PHE 173 n 27 PHE 173 A HIS 174 n 28 HIS 174 A LYS 175 n 29 LYS 175 A SER 175 n 30 A SER 175 A THR 175 n 31 B THR 175 A GLY 175 n 32 C GLY 175 A MET 176 n 33 MET 176 A THR 177 n 34 THR 177 A SER 178 n 35 SER 178 A ARG 179 n 36 ARG 179 A SER 180 n 37 SER 180 A GLY 181 n 38 GLY 181 A THR 182 n 39 THR 182 A ASP 183 n 40 ASP 183 A VAL 184 n 41 VAL 184 A ASP 185 n 42 ASP 185 A ALA 186 n 43 ALA 186 A ALA 187 n 44 ALA 187 A ASN 188 n 45 ASN 188 A LEU 189 n 46 LEU 189 A ARG 190 n 47 ARG 190 A GLU 191 n 48 GLU 191 A THR 192 n 49 THR 192 A PHE 193 n 50 PHE 193 A ARG 194 n 51 ARG 194 A ASN 195 n 52 ASN 195 A LEU 196 n 53 LEU 196 A LYS 197 n 54 LYS 197 A TYR 198 n 55 TYR 198 A GLU 199 n 56 GLU 199 A VAL 200 n 57 VAL 200 A ARG 201 n 58 ARG 201 A ASN 202 n 59 ASN 202 A LYS 203 n 60 LYS 203 A ASN 204 n 61 ASN 204 A ASP 205 n 62 ASP 205 A LEU 206 n 63 LEU 206 A THR 207 n 64 THR 207 A ARG 208 n 65 ARG 208 A GLU 209 n 66 GLU 209 A GLU 210 n 67 GLU 210 A ILE 211 n 68 ILE 211 A VAL 212 n 69 VAL 212 A GLU 213 n 70 GLU 213 A LEU 214 n 71 LEU 214 A MET 215 n 72 MET 215 A ARG 216 n 73 ARG 216 A ASP 217 n 74 ASP 217 A VAL 218 n 75 VAL 218 A SER 219 n 76 SER 219 A LYS 220 n 77 LYS 220 A GLU 221 n 78 GLU 221 A ASP 222 n 79 ASP 222 A HIS 224 n 80 HIS 224 A SER 225 n 81 SER 225 A LYS 226 n 82 LYS 226 A ARG 227 n 83 ARG 227 A SER 228 n 84 SER 228 A SER 229 n 85 SER 229 A PHE 230 n 86 PHE 230 A VAL 231 n 87 VAL 231 A CYS 232 n 88 CYS 232 A VAL 233 n 89 VAL 233 A LEU 234 n 90 LEU 234 A LEU 235 n 91 LEU 235 A SER 236 n 92 SER 236 A HIS 237 n 93 HIS 237 A GLY 238 n 94 GLY 238 A GLU 239 n 95 GLU 239 A GLU 240 n 96 GLU 240 A GLY 241 n 97 GLY 241 A ILE 242 n 98 ILE 242 A ILE 243 n 99 ILE 243 A PHE 244 n 100 PHE 244 A GLY 245 n 101 GLY 245 A THR 246 n 102 THR 246 A ASN 247 n 103 ASN 247 A GLY 254 n 104 GLY 254 A PRO 255 n 105 PRO 255 A VAL 256 n 106 VAL 256 A ASP 257 n 107 ASP 257 A LEU 258 n 108 LEU 258 A LYS 259 n 109 LYS 259 A LYS 260 n 110 LYS 260 A ILE 261 n 111 ILE 261 A THR 262 n 112 THR 262 A ASN 263 n 113 ASN 263 A PHE 264 n 114 PHE 264 A PHE 265 n 115 PHE 265 A ARG 266 n 116 ARG 266 A GLY 267 n 117 GLY 267 A ASP 268 n 118 ASP 268 A ARG 269 n 119 ARG 269 A CYS 270 n 120 CYS 270 A ARG 271 n 121 ARG 271 A SER 272 n 122 SER 272 A LEU 273 n 123 LEU 273 A THR 274 n 124 THR 274 A GLY 275 n 125 GLY 275 A LYS 276 n 126 LYS 276 A PRO 277 n 127 PRO 277 A LYS 278 n 128 LYS 278 A LEU 279 n 129 LEU 279 A PHE 280 n 130 PHE 280 A ILE 281 n 131 ILE 281 A ILE 282 n 132 ILE 282 A GLN 283 n 133 GLN 283 A ALA 284 n 134 ALA 284 A CYS 285 n 135 CYS 285 A ARG 286 n 136 ARG 286 A GLY 287 n 137 GLY 287 A THR 288 n 138 THR 288 A GLU 289 n 139 GLU 289 A LEU 290 n 140 LEU 290 A ASP 291 n 141 ASP 291 A CYS 292 n 142 CYS 292 A GLY 293 n 143 GLY 293 A ILE 294 n 144 ILE 294 A GLU 295 n 145 GLU 295 A n 146 296 A n 147 297 A n 1 310 B n 2 311 B n 3 312 B n 4 313 B n 5 314 B n 6 315 B n 7 316 B n 8 317 B n 9 318 B n 10 319 B LYS 320 n 11 LYS 320 B ILE 321 n 12 ILE 321 B PRO 322 n 13 PRO 322 B VAL 323 n 14 VAL 323 B GLU 324 n 15 GLU 324 B ALA 325 n 16 ALA 325 B ASP 326 n 17 ASP 326 B PHE 327 n 18 PHE 327 B LEU 328 n 19 LEU 328 B TYR 329 n 20 TYR 329 B ALA 330 n 21 ALA 330 B TYR 331 n 22 TYR 331 B SER 332 n 23 SER 332 B THR 333 n 24 THR 333 B ALA 334 n 25 ALA 334 B PRO 335 n 26 PRO 335 B GLY 336 n 27 GLY 336 B TYR 337 n 28 TYR 337 B TYR 338 n 29 TYR 338 B SER 339 n 30 SER 339 B TRP 340 n 31 TRP 340 B ARG 341 n 32 ARG 341 B ASN 342 n 33 ASN 342 B SER 343 n 34 SER 343 B LYS 344 n 35 LYS 344 B ASP 345 n 36 ASP 345 B GLY 346 n 37 GLY 346 B SER 347 n 38 SER 347 B TRP 348 n 39 TRP 348 B PHE 349 n 40 PHE 349 B ILE 350 n 41 ILE 350 B GLN 351 n 42 GLN 351 B SER 352 n 43 SER 352 B LEU 353 n 44 LEU 353 B CYS 354 n 45 CYS 354 B ALA 355 n 46 ALA 355 B MET 356 n 47 MET 356 B LEU 357 n 48 LEU 357 B LYS 358 n 49 LYS 358 B GLN 359 n 50 GLN 359 B TYR 360 n 51 TYR 360 B ALA 361 n 52 ALA 361 B ASP 362 n 53 ASP 362 B LYS 363 n 54 LYS 363 B LEU 364 n 55 LEU 364 B GLU 365 n 56 GLU 365 B PHE 366 n 57 PHE 366 B MET 367 n 58 MET 367 B HIS 368 n 59 HIS 368 B ILE 369 n 60 ILE 369 B LEU 370 n 61 LEU 370 B THR 371 n 62 THR 371 B ARG 372 n 63 ARG 372 B VAL 373 n 64 VAL 373 B ASN 374 n 65 ASN 374 B ARG 375 n 66 ARG 375 B LYS 376 n 67 LYS 376 B VAL 377 n 68 VAL 377 B ALA 378 n 69 ALA 378 B THR 379 n 70 THR 379 B GLU 379 n 71 A GLU 379 B PHE 380 n 72 PHE 380 B GLU 381 n 73 GLU 381 B SER 381 n 74 A SER 381 B PHE 381 n 75 B PHE 381 B SER 381 n 76 C SER 381 B PHE 381 n 77 D PHE 381 B ASP 381 n 78 E ASP 381 B ALA 381 n 79 F ALA 381 B THR 381 n 80 G THR 381 B PHE 381 n 81 H PHE 381 B HIS 381 n 82 I HIS 381 B ALA 382 n 83 ALA 382 B LYS 383 n 84 LYS 383 B LYS 384 n 85 LYS 384 B GLN 385 n 86 GLN 385 B ILE 386 n 87 ILE 386 B PRO 387 n 88 PRO 387 B CYS 388 n 89 CYS 388 B ILE 389 n 90 ILE 389 B VAL 390 n 91 VAL 390 B SER 392 n 92 SER 392 B MET 393 n 93 MET 393 B LEU 394 n 94 LEU 394 B THR 395 n 95 THR 395 B LYS 396 n 96 LYS 396 B GLU 397 n 97 GLU 397 B LEU 398 n 98 LEU 398 B TYR 399 n 99 TYR 399 B PHE 400 n 100 PHE 400 B TYR 401 n 101 TYR 401 B n 102 402 B ACE 501 n 1 ACE 501 C ASP 502 n 2 ASP 502 C GLU 503 n 3 GLU 503 C VAL 504 n 4 VAL 504 C ASJ 505 n 5 ASJ 505 C author_and_software_defined_assembly PISA 3 trimeric software_defined_assembly PISA 12 dodecameric software_defined_assembly PISA 6 hexameric 5390 -31 10940 33490 -177 31800 15180 -83 17460 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 -1.0000000000 0.0000000000 0.0000000000 0.0000000000 -1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 2_675 -x+1,-y+2,z crystal symmetry operation 69.8100000000 169.2400000000 0.0000000000 -1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 -1.0000000000 3_655 -x+1,y,-z crystal symmetry operation 69.8100000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 -1.0000000000 0.0000000000 0.0000000000 0.0000000000 -1.0000000000 4_575 x,-y+2,-z crystal symmetry operation 0.0000000000 169.2400000000 0.0000000000 A N ARG 201 A N ARG 58 A O CYS 165 A O CYS 19 A N ILE 166 A N ILE 20 A O VAL 231 A O VAL 87 A N CYS 232 A N CYS 88 A O LEU 279 A O LEU 129 A N PHE 280 A N PHE 130 B O LEU 328 B O LEU 19 B N TYR 329 B N TYR 20 B O VAL 390 B O VAL 91 B N GLY 346 B N GLY 37 B O ASN 342 B O ASN 33 B N ARG 341 B N ARG 32 C O GLU 503 C O GLU 3 A N GLU 239 A N GLU 95 A O ILE 242 A O ILE 98 A N ILE 243 A N ILE 99 A O VAL 256 A O VAL 106 1 A SER 145 A SER 1 1 Y 1 A GLY 146 A GLY 2 1 Y 1 A ILE 147 A ILE 3 1 Y 1 A SER 148 A SER 4 1 Y 1 A LEU 149 A LEU 5 1 Y 1 A THR 296 A THR 146 1 Y 1 A ASP 297 A ASP 147 1 Y 1 B SER 310 B SER 1 1 Y 1 B GLY 311 B GLY 2 1 Y 1 B VAL 312 B VAL 3 1 Y 1 B ASP 313 B ASP 4 1 Y 1 B ASP 314 B ASP 5 1 Y 1 B ASP 315 B ASP 6 1 Y 1 B MET 316 B MET 7 1 Y 1 B ALA 317 B ALA 8 1 Y 1 B CYS 318 B CYS 9 1 Y 1 B HIS 319 B HIS 10 1 Y 1 B HIS 402 B HIS 102 1 Y 1 A SER 236 -177.47 -176.93 1 B LYS 363 -143.41 -38.30 1 B PHE 400 -102.26 42.08 PARHCSDX.PRO TOPHCSDX.PRO APOPAIN.PAR APOPAIN.PRO 23.56 THERE IS NO ELECTRON DENSITY FOR RESIDUES A 145 - A 149, A 296 - A 297, B 310 - B 319, AND B 402, PRESUMABLY DUE TO DISORDER. MASS SPECTROMETRY INDICATES THAT THESE RESIDUES ARE PRESENT IN THE SPECIES CRYSTALLIZED. 0.2750000 0.1950000 0.1950000 2.5 20. 845 7987 10.6 78. RANDOM 1 FREE-R 2. MOLECULAR REPLACEMENT PROTEIN COMPONENT OF INTERLEUKIN-1BETA CONVERTING ENZYME (PDB ENTRY 1ICE) 2.5 20. 34 1939 0 0 1905 0.007 1.308 24.14 1.091 0.3300000 0.2570000 2.59 38 321 10.6 35.8 31.34 2.50 36.0 1PAU 8929 0.0 0.0634000 0.0555000 1 17.4 2.33 87.1 0.2570000 2.50 2.59 2.59 0.2620000 1 2.27 87.1 model building X-PLOR 3.1 refinement X-PLOR 3.1 data reduction SAINT data scaling SAINT phasing X-PLOR 3.1 Crystal structure of the complex of apopain with the tetrapeptide aldehyde inhibitor AC-DEVD-CHO 1 N N 2 N N 3 N N 4 N N 4 N N 4 N N A THR 182 A THR 39 HELX_P A ASN 195 A ASN 52 1 A 14 A ARG 208 A ARG 65 HELX_P A LYS 220 A LYS 77 1 B 13 A LEU 258 A LEU 108 HELX_P A PHE 264 A PHE 114 1 C 7 B TRP 348 B TRP 39 HELX_P B ALA 361 B ALA 52 1 D 14 B PHE 366 B PHE 57 HELX_P B GLU 379 B GLU 71 1 E 15 A covale 1.772 one A CYS 285 A SG CYS 135 1_555 C ASJ 505 C C ASJ 5 1_555 covale 1.327 both C ACE 501 C C ACE 1 1_555 C ASP 502 C N ASP 2 1_555 covale 1.334 both C VAL 504 C C VAL 4 1_555 C ASJ 505 C N ASJ 5 1_555 HYDROLASE/HYDROLASE INHIBITOR CYSTEINE PROTEASE, CASPASE-3, APOPAIN, CPP32, YAMA, PROTEASE-INHIBITOR COMPLEX, HYDROLASE-HYDROLASE INHIBITOR COMPLEX ICE3_HUMAN UNP 1 1 P42574 SGISLDNSYKMDYPEMGLCIIINNKNFHKSTGMTSRSGTDVDAANLRETFRNLKYEVRNKNDLTREEIVELMRDVSKEDH SKRSSFVCVLLSHGEEGIIFGTNGPVDLKKITNFFRGDRCRSLTGKPKLFIIQACRGTELDCGIETD ICE3_HUMAN UNP 2 1 P42574 SGVDDDMACHKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVNRKVATEFESFSFDAT FHAKKQIPCIVSMLTKELYFYH 1PAU PDB 3 1PAU 29 175 1PAU 145 297 P42574 A 1 1 147 176 277 1PAU 310 402 P42574 B 2 1 102 501 505 1PAU 501 505 1PAU C 3 1 5 6 3 3 parallel parallel parallel parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel A GLU 199 A GLU 56 A ASN 204 A ASN 61 A GLU 162 A GLU 15 A ASN 169 A ASN 23 A ARG 227 A ARG 83 A LEU 235 A LEU 91 A LYS 278 A LYS 128 A GLN 283 A GLN 133 B PHE 327 B PHE 18 B TYR 331 B TYR 22 B CYS 388 B CYS 89 B MET 393 B MET 93 B GLY 346 B GLY 37 B SER 347 B SER 38 B TRP 340 B TRP 31 B ASN 342 B ASN 33 C ASP 502 C ASP 2 C VAL 504 C VAL 4 A GLY 238 A GLY 94 A GLU 239 A GLU 95 A ILE 242 A ILE 98 A GLY 245 A GLY 101 A GLY 254 A GLY 104 A ASP 257 A ASP 107 INHIBITOR BINDING SUB-SITE S1. Unknown 10 INHIBITOR BINDING SUB-SITE S2. Unknown 6 INHIBITOR BINDING SUB-SITE S3. Unknown 6 INHIBITOR BINDING SUB-SITE S4. Unknown 8 BINDING SITE FOR CHAIN C OF ACE-ASP-GLU-VAL-ASA Software 15 A ARG 179 A ARG 36 10 1_555 A SER 236 A SER 92 10 1_555 A HIS 237 A HIS 93 10 1_555 A GLY 238 A GLY 94 10 1_555 A GLN 283 A GLN 133 10 1_555 A ALA 284 A ALA 134 10 1_555 A CYS 285 A CYS 135 10 1_555 B SER 339 B SER 30 10 1_555 B TRP 340 B TRP 31 10 1_555 B ARG 341 B ARG 32 10 1_555 A CYS 285 A CYS 135 6 1_555 B TYR 338 B TYR 29 6 1_555 B SER 339 B SER 30 6 1_555 B TRP 340 B TRP 31 6 1_555 B ARG 341 B ARG 32 6 1_555 B PHE 381 B PHE 81 H 6 1_555 A SER 178 A SER 35 6 1_555 A ARG 179 A ARG 36 6 1_555 A SER 180 A SER 37 6 1_555 B TRP 340 B TRP 31 6 1_555 B ARG 341 B ARG 32 6 1_555 B SER 343 B SER 34 6 1_555 B TRP 340 B TRP 31 8 1_555 B ARG 341 B ARG 32 8 1_555 B ASN 342 B ASN 33 8 1_555 B GLY 346 B GLY 37 8 1_555 B SER 347 B SER 38 8 1_555 B TRP 348 B TRP 39 8 1_555 B SER 381 B SER 74 A 8 1_555 B PHE 381 B PHE 75 B 8 1_555 A SER 175 A SER 30 A 15 2_675 A ARG 179 A ARG 36 15 1_555 A HIS 237 A HIS 93 15 1_555 A GLN 283 A GLN 133 15 1_555 A CYS 285 A CYS 135 15 1_555 B TYR 338 B TYR 29 15 1_555 B SER 339 B SER 30 15 1_555 B TRP 340 B TRP 31 15 1_555 B ARG 341 B ARG 32 15 1_555 B ASN 342 B ASN 33 15 1_555 B SER 343 B SER 34 15 1_555 B SER 381 B SER 74 A 15 1_555 B PHE 381 B PHE 75 B 15 1_555 B HOH 626 E HOH 15 1_555 C HOH 619 F HOH 15 1_555 23 I 2 2 2